- $892.34m
- $782.02m
- $200.93m
SI-BONE Inc reports results for the quarter ended June 30 - Earnings Summary
SI-BONE Q2 revenue beats estimates, raises 2026 revenue outlook
Brief: SI-BONE Q2 Revenue USD 56.01 Million Vs. IBES Estimate USD 55.3 Million
U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis
SI-BONE beats Q1 revenue estimates; lifts 2026 guidance
Brief: SI-BONE Q1 Revenue USD 52.588 Million Vs. IBES Estimate USD 51.1 Million
Brief: Si-Bone Files For Mixed Shelf Size Not Disclosed
SI-BONE Q4 revenue rises
Brief: SI-BONE Q4 Revenue USD 56.35 Million Vs. IBES Estimate USD 55.9 Million
U.S. RESEARCH ROUNDUP-AMETEK, Stryker, Zimmer Biomet Holdings
Spine implant maker SI-BONE's Q3 revenue beats estimates
Brief: SI-BONE Q3 Revenue USD 48.656 Million Vs. IBES Estimate USD 46.7 Million
Brief: SI-BONE Q2 Revenue USD 48.63 Million Vs. IBES Estimate USD 48.1 Million
SI-BONE Inc reports results for the quarter ended March 31 - Earnings Summary
SI-BONE Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: SI-BONE Q4 Revenue USD 49.002 Million Vs. IBES Estimate USD 47.9 Million
SI-BONE Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: SI-BONE Q3 Revenue USD 40.34 Million Vs. IBES Estimate USD 40.5 Million
Brief: Si-Bone Announces First-In-Patient Procedures With FDA Breakthrough Device For Pelvic Fracture Fixation